- Home
- TEO vs TVTX Comparison
TEO vs TVTX Comparison
Compare TEO & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEO | TVTX |
|---|---|---|
| Founded | 1979 | N/A |
| Country | Argentina | United States |
| Employees | 27818 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.3B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | TEO | TVTX |
|---|---|---|
| Price | $14.86 | $53.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $12.30 | ★ $40.62 |
| AVG Volume (30 Days) | 651.3K | ★ 1.8M |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | N/A | ★ 92.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.91 | $44.76 |
| Revenue Next Year | $1.58 | $35.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.43 | $13.88 |
| 52 Week High | $16.34 | $53.88 |
Technical Indicators
Market Signals| Indicator | TEO | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.95 | 71.29 |
| Support Level | $11.00 | $41.75 |
| Resistance Level | $15.32 | N/A |
| Average True Range (ATR) | 0.81 | 2.42 |
| MACD | 0.12 | 0.62 |
| Stochastic Oscillator | 48.63 | 95.21 |
Price Performance
Historical ComparisonAbout TEO Telecom Argentina SA
Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company operates in segments: ICT Services provided in Argentina: Personal Network; ICT Services provided in Argentina - TMA Network; and Other segments..
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.